Evidence map›Paper›PMID 30858773›Full record

ReviewPostepy dermatologii i alergologii2019

Leszek Blicharz, Lidia Rudnicka, Zbigniew Samochocki

Abstract readReview
In one paragraph

Review in Postepy dermatologii i alergologii, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Correlation betweenFrontiers in immunology · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Silver sulfadiazine in modern dermatology.Dermatology online journal · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Bacterial Skin Dysbiosis in Darier Disease.Dermatology (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Towards sustainable antimicrobial therapies forSustainable microbiology · 2024
    Review
  14. Review
  15. Article
  16. A Wall Fragment ofPharmaceutics · 2023
    Article
  17. Frontiers in cellular and infection microbiology · 2023
    Review
  18. Butyrate inhibitsFrontiers in immunology · 2023
    Article
  19. The Role ofInternational journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leszek BlicharzDepartment of Dermatology, Medical University of Warsaw, Warsaw, Poland.
Lidia RudnickaDepartment of Dermatology, Medical University of Warsaw, Warsaw, Poland.
Zbigniew SamochockiDepartment of Dermatology, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis is a common, recurrent pruritic dermatosis with a complex pathogenesis. It has been associated with disordered patterns of immunological response and impaired epithelial barrier integrity. These features predispose the patients to robust colonization of skin lesions by

Indexed as

atopic dermatitispathogenesisStaphylococcus aureus

Identifiers

PMID30858773
PMCPMC6409874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.